Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-30 to 2024-07-31
Current total value of award: $6.41
Description: 4565293027!INSULIN HUMAN INJECTION MODIFIED 100 USP